BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31938965)

  • 1. Assessing health-related quality of life in cancer survivors: factors impacting on EORTC QLU-C10D-derived utility values.
    van Gelder T; Mulhern B; Schoormans D; Husson O; De Abreu Lourenço R
    Qual Life Res; 2020 Jun; 29(6):1483-1494. PubMed ID: 31938965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dutch utility weights for the EORTC cancer-specific utility instrument: the Dutch EORTC QLU-C10D.
    Jansen F; Verdonck-de Leeuw IM; Gamper E; Norman R; Holzner B; King M; Kemmler G;
    Qual Life Res; 2021 Jul; 30(7):2009-2019. PubMed ID: 33512653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian Utility Weights for the EORTC QLU-C10D, a Multi-Attribute Utility Instrument Derived from the Cancer-Specific Quality of Life Questionnaire, EORTC QLQ-C30.
    King MT; Viney R; Simon Pickard A; Rowen D; Aaronson NK; Brazier JE; Cella D; Costa DSJ; Fayers PM; Kemmler G; McTaggart-Cowen H; Mercieca-Bebber R; Peacock S; Street DJ; Young TA; Norman R;
    Pharmacoeconomics; 2018 Feb; 36(2):225-238. PubMed ID: 29270835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30.
    Kemmler G; Gamper E; Nerich V; Norman R; Viney R; Holzner B; King M;
    Qual Life Res; 2019 Dec; 28(12):3197-3211. PubMed ID: 31485913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese value set for the EORTC QLU-C10D: A multi-attribute utility instrument based on the EORTC QLQ-C30 cancer-specific quality-of-life questionnaire.
    Shiroiwa T; King MT; Norman R; Müller F; Campbell R; Kemmler G; Murata T; Shimozuma K; Fukuda T
    Qual Life Res; 2024 May; ():. PubMed ID: 38724771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. United States Utility Algorithm for the EORTC QLU-C10D, a Multiattribute Utility Instrument Based on a Cancer-Specific Quality-of-Life Instrument.
    Revicki DA; King MT; Viney R; Pickard AS; Mercieca-Bebber R; Shaw JW; Müller F; Norman R
    Med Decis Making; 2021 May; 41(4):485-501. PubMed ID: 33813946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. U.K. utility weights for the EORTC QLU-C10D.
    Norman R; Mercieca-Bebber R; Rowen D; Brazier JE; Cella D; Pickard AS; Street DJ; Viney R; Revicki D; King MT;
    Health Econ; 2019 Dec; 28(12):1385-1401. PubMed ID: 31482619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EORTC QLU-C10D: The Canadian Valuation Study and Algorithm to Derive Cancer-Specific Utilities From the EORTC QLQ-C30.
    McTaggart-Cowan H; King MT; Norman R; Costa DSJ; Pickard AS; Regier DA; Viney R; Peacock SJ
    MDM Policy Pract; 2019; 4(1):2381468319842532. PubMed ID: 31245606
    [No Abstract]   [Full Text] [Related]  

  • 9. EORTC QLU-C10D value sets for Austria, Italy, and Poland.
    Gamper EM; King MT; Norman R; Efficace F; Cottone F; Holzner B; Kemmler G;
    Qual Life Res; 2020 Sep; 29(9):2485-2495. PubMed ID: 32458409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. French Value-Set of the QLU-C10D, a Cancer-Specific Utility Measure Derived from the QLQ-C30.
    Nerich V; Gamper EM; Norman R; King M; Holzner B; Viney R; Kemmler G
    Appl Health Econ Health Policy; 2021 Mar; 19(2):191-202. PubMed ID: 32537694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients.
    Pan CW; He JY; Zhu YB; Zhao CH; Luo N; Wang P
    Eur J Health Econ; 2023 Aug; 24(6):885-893. PubMed ID: 36083356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients-Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs.
    Pilz MJ; Seyringer S; Al-Naesan I; King MT; Bottomley A; Norman R; Schlosser L; Hell T; Gamper EM;
    Pharmacoecon Open; 2024 May; ():. PubMed ID: 38696019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European Organisation for Research and Treatment of Cancer Quality of Life Utility-Core 10 Dimensions: Development and Investigation of General Population Utility Norms for Canada, France, Germany, Italy, Poland, and the United Kingdom.
    Pilz MJ; Nolte S; Liegl G; King M; Norman R; McTaggart-Cowan H; Bottomley A; Rose M; Kemmler G; Holzner B; Gamper EM;
    Value Health; 2023 May; 26(5):760-767. PubMed ID: 36572102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
    Bulamu NB; Vissapragada R; Chen G; Ratcliffe J; Mudge LA; Smithers BM; Isenring EA; Smith L; Jamieson GG; Watson DI;
    Health Qual Life Outcomes; 2021 Oct; 19(1):233. PubMed ID: 34600554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EORTC QLU-C10D: the Hong Kong valuation study.
    Xu RH; Wong EL; Luo N; Norman R; Lehmann J; Holzner B; King MT; Kemmler G;
    Eur J Health Econ; 2023 Sep; ():. PubMed ID: 37768519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Danish value sets for the EORTC QLU-C10D utility instrument.
    Lehmann J; Rojas-Concha L; Petersen MA; Holzner B; Norman R; King MT; Kemmler G;
    Qual Life Res; 2024 Mar; 33(3):831-841. PubMed ID: 38183563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.
    King MT; Costa DS; Aaronson NK; Brazier JE; Cella DF; Fayers PM; Grimison P; Janda M; Kemmler G; Norman R; Pickard AS; Rowen D; Velikova G; Young TA; Viney R
    Qual Life Res; 2016 Mar; 25(3):625-36. PubMed ID: 26790428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of Health-Related Utilities for
    Soare IA; Leeuwenkamp O; Longworth L
    Pharmacoecon Open; 2021 Dec; 5(4):715-725. PubMed ID: 34260017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health state utility differed systematically in breast cancer patients between the EORTC QLU-C10D and the PROMIS Preference Score.
    Klapproth CP; Fischer F; Rose M; Karsten MM
    J Clin Epidemiol; 2022 Dec; 152():101-109. PubMed ID: 36162712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EORTC QLU-C10D discrete choice experiment for cancer patients: a first step towards patient utility weights.
    Gamper EM; King MT; Norman R; Loth FLC; Holzner B; Kemmler G;
    J Patient Rep Outcomes; 2022 May; 6(1):42. PubMed ID: 35507194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.